Skip to content
𝗕𝗿𝗲𝗮𝗸 𝙏𝙝𝙧𝙤𝙪𝙜𝙝 𝗖𝗮𝗻𝗰𝗲𝗿· @break_cancer · X·· 2026-04-20Score60

#GLIOBLASTOMA

Reading

The rest: ovarian, HNSCC, GBM and other floor tumors

Body

Sunday at #AACR26 and the science continues.

Work from our Accelerating GBM Therapies Through Serial Biopsies TeamLab highlights a key challenge in #Glioblastoma: biomarker signatures vary across patients—and even within the same tumor over time (abstract 1055)

Looking forward

Heat 2 · 2 likes · 0 replies · 0 reposts

Source: 𝗕𝗿𝗲𝗮𝗸 𝙏𝙝𝙧𝙤𝙪𝙜𝙝 𝗖𝗮𝗻𝗰𝗲𝗿 · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org